Geneoscopy’s Dr. Erica Barnell to Present at Women @ Work Summit and American Gastroenterological Association (AGA) Workshop
Presentations to inspire the next generation of woman scientists and highlight recent advancements in colorectal cancer screening ST. LOUIS, Mo. –…
Geneoscopy Receives New York State Department of Health Permit, Expanding Ability to Provide Laboratory Services Nationwide
ST. LOUIS, Mo. – October 1, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Geneoscopy to Present at Gastroenterology and Cancer Surveillance Conferences, Highlighting Advancements in Colorectal Cancer Screening and Early Detection
ST. LOUIS, Mo. – August 4, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Geneoscopy’s CEO Andrew Barnell to Present at Upcoming Investor Conferences
ST. LOUIS, Mo. – August 8, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Geneoscopy’s Novel Stool-Based RNA Platform Shows High Accuracy in Monitoring Crohn’s Disease
ST. LOUIS, Mo. – August 1, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of ‘781 Patent Owned by Exact Sciences
ST. LOUIS, Mo. – July 29, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Peer-Reviewed Study Confirms Reliability of ColoSense, Geneoscopy’s Noninvasive Multi-target Stool RNA Colorectal Cancer Screening Test
ST. LOUIS, Mo. – July 10, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Geneoscopy Files Counterclaims Against Exact Sciences
The Company is confident that litigation will not delay the commercial launch of ColoSense™, its FDA-approved RNA biomarker screening test for…
Geneoscopy Advances Mission to Transform Gastrointestinal Health at Digestive Disease Week 2024
Company highlights capabilities of noninvasive stool-based RNA technology platform for improving patient outcomes in IBD and CRC ST, LOUIS, MO – MAY…